Kimberly is a freelance health, travel, and lifestyle writer and editor living in Birmingham, AL. She has previously written for Cooking Light, Eating Well, Coastal Living, Real Simple, Reader’s Digest, and more. When she’s not writing, you’ll likely find her watching âMurder, She Wroteâ and sorting her collection of books that she’ll certainly one day find time to read, or planning her next vacation, preferably to an island, please.\n"},"avatar":{"title":"","width":200,"height":200,"src":"https://post.healthline.com/wp-content/uploads/2019/03/200x200_Kimberly_Holland.png"}}],"medicalReviewers":[{"id":115,"name":{"display":"Alan Carter, Pharm.D.","first":"Alan","last":"Carter, PharmD"},"userLogin":"achealthline","links":{"website":"","facebook":"","linkedin":"https://www.linkedin.com/in/alancarterpharmd/","twitter":"","instagram":"","tiktok":""},"link":"/reviewers/alan-carter-pharmd","type":{"value":"medical_reviewer","label":"Medical Advisor"},"nid":"122506","specialties":[],"guestTitle":"","bio":{"text":"
This individual is no longer a medical reviewer in our network. The credentials and contact information reflected here may not be current.\n
Dr. Alan Carter is a clinical pharmacist with interests in medical research, pharmacy practice, and medication formulary management. He is an independent contracted medical director for pharmaceutical development, clinical pharmacy specialist, and adjunct clinical assistant professor of pharmacy.\n
Education\n
\n
University of Missouri – Kansas City, BS, PharmD\n\n
Certifications\n
\n
Licensed Pharmacist\n
Kansas Board of Pharmacy\n
Missouri Board of Pharmacy\n
Certified Immunizing Pharmacist\n
Certified Smoking Cessation Specialist\n\n
Professional Accomplishments\n
\n
Published 20 journal articles to date, performs medical journal peer review, and serves on many professional committees and boards\n
Awarded the Pharmacy Career Achievement Award by the University of Missouri – Kansas City, 2019\n
Served as principal investigator for the National Institutes of Health, NINDS BRAIN Initiative for Neurological Drug Development, 2015-2018\n\n
Treatment for major depressive disorder (also known as major depression, clinical depression, unipolar depression, or MDD) depends on the individual and the severity of the illness. However, doctors often discover the best results when both prescription medications, such as antidepressants, and psychotherapy are used in combination.
Currently, more than two-dozen antidepressant medications are available.
Antidepressants are successful in treating depression, but no single medication has been shown to be the most effective â it depends entirely on the patient and their individual circumstances. Youâll have to take the medication regularly for several weeks in order to see results and observe any side effects.
Here are the most frequently prescribed antidepressant medicines and their most common side effects.
When the brain doesnât make enough serotonin, or it canât use existing serotonin correctly, the balance of chemicals in the brain may become uneven. SSRIs work to change the level of serotonin in the brain.
Specifically, SSRIs block the reabsorption of serotonin. By blocking the reabsorption, neurotransmitters may send and receive chemical messages more effectively. This is thought to increase the mood-boosting effects of serotonin and improve depression symptoms.
With additional serotonin and norepinephrine circulating in the brain, the brainâs chemical balance may be reset, and neurotransmitters are thought to communicate more effectively. This may improve mood and help relieve symptoms of depression.
Tricyclic antidepressants (TCAs) were invented in the 1950s, and they were among the earliest antidepressants utilized to treat depression.
TCAs work by blocking the reabsorption of noradrenaline and serotonin. This may help the body prolong the mood-boosting benefits of the noradrenaline and serotonin it releases naturally, which can improve mood and reduce the effects of depression.
Many doctors prescribe TCAs because theyâre thought to be as safe as newer medicines.
Monoamine oxidase inhibitors (MAOIs) are medications that are typically prescribed only when several other medications and treatments have failed.
MAOIs prevent the brain from breaking down the chemicals norepinephrine, serotonin, and dopamine. This allows the brain to maintain higher levels of these chemicals, which may boost mood and improve neurotransmitter communications.
MAOIs tend to have multiple side effects, many of them serious and harmful. MAOIs also have the potential for dangerous interactions with foods and over-the-counter medications.
The most common side effects experienced by people who use MAOIs include:
daytime sleepiness
insomnia
dizziness
low blood pressure
dry mouth
nervousness
weight gain
reduced sexual desire or difficulty reaching orgasm
For treatment-resistant depression or for patients who continue to have unresolved symptoms, a secondary medication may be prescribed.
These add-on medications are generally used to treat other mental health disorders and may include anti-anxiety medications, mood stabilizers, and antipsychotics.
Examples of antipsychotics that have been approved by the Food and Drug Administration (FDA) for use as add-on therapies for depression include:
Atypical medications, or those that donât fit into any of the other drug categories, include mirtazapine (Remeron) and trazodone (Oleptro).
The main side effect of these medications is drowsiness. Because both of these medicines can cause sedation, theyâre typically taken at night to prevent attention and focus problems.
Â
How we reviewed this article:
Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.